Article
How to drug a leukemic stem cell: deciphering heterogeneity for better specificity
25 Jul 2025
Abstract excerpt
Blood cancers, such as acute myeloid leukemia (AML), are becoming increasingly common due to an aging population but remain challenging to treat. Relapse is the most important singular cause of treatment failure in AML, and up to half of patients relapse after chemotherapy or bone marrow transplantation. Relapse in AML is primarily due to a population of quiescent leukemic stem cells (LSCs) that shelter in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
